Nasdaq Panel Denies OSR Health Appeal, Orders Delisting; Plan Due by November 6
OSRHW has more than doubled off its 52-week low of $0.005.
Summary
Nasdaq's Hearings Panel denied OSR Health's appeal and will delist its common stock and warrants, which already trade over-the-counter. By November 6, 2026, the company says it will present a plan to regain a national exchange listing.
Key Events · Legal and Risk Events · OSRHW
-
Nasdaq Panel Orders Delisting
On October 23, 2026, the Nasdaq Hearings Panel denied OSR Health's request for continued listing and determined to delist its common stock and warrants for failing the $1.00 minimum bid price rule.
-
Shares Already Trade OTC
Trading on Nasdaq was suspended at the open on August 26, 2026; the securities have since quoted over-the-counter as OSRH and OSRHW, and the company remains an SEC-reporting issuer.
-
No Reverse Split Pursued
Management states it chose not to pursue a reverse stock split during the compliance process, betting the share price would reflect business progress instead.
-
Relisting Plan Due November 6
The company says it is evaluating strategic and corporate alternatives and will provide a further update on its plan to regain a national securities exchange listing on or before November 6, 2026.
Analysis · OSRHW · Industrial Applications And Services
What had been a suspension is now a definitive delisting: on October 23, 2026, the Nasdaq Hearings Panel formally denied OSR Health's request for continued listing. The stock already trades over-the-counter under OSRH and OSRHW, so the practical change is the loss of national-exchange status — thinner liquidity, restricted institutional ownership, and a harder path to raising capital. Management says it will not do a reverse split and will outline a plan to regain a national exchange by November 6, 2026. The $15 million VXM01 put option with BCM Europe AG remains the funding backstop, now settleable in convertible notes at roughly $2.00 to $5.00 per share — a wide gap from the current $0.0113 quote, so the realistic conversion math depends heavily on where the stock actually trades.
How filings like this one have moved
In the 30 days to Oct 28, 2026, 45.8% of the 251 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.67%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, OSRHW was trading at $0.01 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $7M. The 52-week trading range was $0.01 to $0.10. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.